EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients

Chiara Colarusso, Michela Terlizzi, Anna Falanga, Georgious Stathopoulos, Luigi De Lucia, Phillip M Hansbro, Aldo Pinto, Rosalinda Sorrentino

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Chiara Colarusso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Salerno, Italy. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Melanoma, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of Technology Sydney, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The absent in melanoma 2 (AIM2) inflammasome has been demonstrated as involved in tumor growth. In this study we used human samples of lung adenocarcinoma (LUAD) patients, taking advantage of a mouse model of smoking cessation. Human samples were stratified according to the smoking status, high-risk factor for this type of tumor. Both public transcriptomic and human samples obtained by a clinical trial proved that AIM2 was upregulated either in terms of mRNA or protein, respectively, in the tumor mass according to the TNM stage, but it did not relate to the smoking status, age and sex. The upregulation of AIM2 was correlated to an immunosuppressive environment according to resting/non-active dendritic cells (DCs) and T regulatory cells, as demonstrated in both human samples and by means of an experimental model of smoking mice. Computational analysis showed that AIM2 upregulation was correlated to both an inflammasome profile, responsible for the poor prognosis of non-smoker and smoker LUAD patients, and to a non-inflammasome profile for former smoker. In conclusion, our study demonstrated that AIM2 is involved in lung carcinogenesis either in a canonical and non-canonical manner due to an immunosuppressive microenvironment associated to a dismal prognosis of LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungMelanomaLung NeoplasmsHumansMiceAnimalsInflammasomesPrognosisTumor MicroenvironmentDNA-Binding Proteins

Stichwörter der Autor:innen

AIM2 inflammasomeLung adenocarcinomaSmokeSmoking habitTranscriptomic signature

Substanzen

InflammasomesAIM2 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pharmacy, University of Salerno, Italy.
  • Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Patras, Greece.
  • Centre for Inflammation, Centenary Institute and University of Technology Sydney (UTS), School of Life Sciences, Faculty of Science, Sydney, NSW 2007, Australia.
  • Department of Pharmacy, University of Salerno, Italy. Electronic address: rsorrentino@unisa.it.

Förderung

  • National Health and Medical Research Council
  • University of Technology Sydney
  • European Cooperation in Science and Technology

Zitieren

APA

Colarusso, C., Terlizzi, M., Falanga, A., Stathopoulos, G., De Lucia, L., Hansbro, P. M., Pinto, A., & Sorrentino, R. (2023). Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110990

Vancouver

Colarusso C, Terlizzi M, Falanga A, Stathopoulos G, De Lucia L, Hansbro PM, et al. Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110990

BibTeX
@article{Colarusso2023,
  author = {Colarusso, Chiara and Terlizzi, Michela and Falanga, Anna and Stathopoulos, Georgious and De Lucia, Luigi and Hansbro, Phillip M and Pinto, Aldo and Sorrentino, Rosalinda},
  title = {Absent in melanoma 2 (AIM2) positive profile identifies a poor prognosis of lung adenocarcinoma patients},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110990}
}
Kostenlos starten →